Products
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | 5.0 | - |
Min SIP Amount | ₹500 | - |
Expense Ratio | 1.93 | - |
NAV | ₹437.89 | - |
Fund Started | 04 Jun 1999 | - |
Fund Size | ₹3933.26 Cr | - |
Exit Load | Exit load of 0.50% if redeemed within 15 days | - |
Risk
Very High
-
Rating
5.0
-
Min SIP Amount
₹500
-
Expense Ratio
1.93
-
NAV
₹437.89
-
Fund Started
04 Jun 1999
-
Fund Size
₹3933.26 Cr
-
Exit Load
Exit load of 0.50% if redeemed within 15 days
-
Returns
1 Year | 7.07% | - |
3 Year | 25.68% | - |
5 Year | 19.81% | - |
1 Year
7.07%
-
3 Year
25.68%
-
5 Year
19.81%
-
Holding Analysis
Equity | 96.36% | - |
Cash | 3.56% | - |
Equity
96.36%
-
Cash
3.56%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.94% |
Divi's Laboratories Ltd. | 6.36% |
Max Healthcare Institute Ltd. | 5.67% |
Cipla Ltd. | 4.59% |
Lupin Ltd. | 4.08% |
Lonza Group Ag | 4.06% |
Fortis Healthcare Ltd. | 3.70% |
Torrent Pharmaceuticals Ltd. | 3.66% |
Gland Pharma Ltd. | 3.54% |
Mankind Pharma Ltd. | 3.34% |
-
Fund Manager
Name | Tanmaya Desai | - |
Start Date | 17 May 2024 | - |
Name
Tanmaya Desai
-
Start Date
17 May 2024
-
About Fund
Description | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. | - |
Launch Date | 04 Jun 1999 | - |
Description
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
-
Launch Date
04 Jun 1999
-